Dr. Devika S. Kumar is a biomedical researcher with multidisciplinary expertise spanning biochemistry, neurobiology, infectious diseases, and translational medicine. She has been extensively trained in advanced laboratory methods, including RT-PCR diagnostics, flow cytometry, and pre-clinical animal research, with certifications from national and international bodies including WHO, NABL, and specialized research institutions.

Over the years, she has participated in high-impact scientific conferences, workshops, and professional courses across India, gaining wide exposure in areas such as nanoscience, endocrine research, oncology, pharmacology, and intellectual property rights.

Research Interests

Her research contributions cover several domains, particularly:

• Neurodegenerative disorders (Parkinson’s disease models, microglial dysfunction)

• Autism spectrum disorder biomarkers

• COVID-19 diagnostics, epidemiology, and vaccine development

• Tumor microenvironment and cancer therapeutics

• Oxidative stress markers and metabolic disorders

Achievements, Certifications & Professional Affiliations

• Fellow of Scholars Academic & Scientific Society (FSASS), 2021

• Young Researcher Award (2022) – Indian Institute of Scholars
  (for work on extracellular oxidative stress markers in COVID-19)

• Professional Membership – InSc International (entitled to use LMINC)

• Reviewer – Basic & Medical Sciences Journal

• WHO Certifications in COVID-19 surveillance, infection control, mask use, vaccination deployment, environmental disinfection, occupational safety, and health emergencies

• NABL-CAHO training in RT-PCR RNA testing accreditation processes

• Extensive training in Rotor-Gene Q5 Plex HRM operation and interpretation

• Certified training in preclinical animal surgery and handling

Patents

Dr. Devika S. Kumar is co-inventor on multiple nationally published Indian patents, mainly focused on novel PPE technologies and biomedical devices, including:

1. Six-layer N95 protective mask (2021)

2. Universal weightless PPE headgear (2020)

3. Transparent, expression-friendly antimicrobial facemask (2020–2022)

4. Airtight, leakproof antiviral facemask (2020)

5. Transcallosal neuromodulating Brain–Machine Interface (2020)

These innovations gained relevance during the COVID-19 pandemic and demonstrate her leadership in applied scientific innovation.

Publications

Dr. Kumar has authored numerous research articles and book chapters across reputable journals, including Cureus, Clinics and Practice, IJPSR, International Journal of Oncology Trends, Life Sciences–Neuroscience, and others. Her works address:

• Microglial roles in neurodevelopmental disorders (2025)

• Stem cell therapeutics in Parkinson’s disease (2025)

• Biomarkers of autism severity (2024)

• COVID-19 vaccine development challenges (2024)

• AI applications in women’s health (2024)

• Tumor microenvironment variability (2024)

• Oxidative stress markers in diabetic COVID-19 patients (2022)

• Pediatric inflammatory syndromes and neurodevelopment (2022)

Her early contributions include community COVID-19 screening tools recognized in the WHO COVID-19 database.

Scientific Contributions & Impact

Dr. Kumar’s body of work demonstrates:

• Translational focus bridging bench-to-bedside innovation

• Strong productivity in COVID-19 research, neurobiology, pediatric health, and immunology

• Collaborative output with clinicians, neuroscientists, and global researchers

• Significant patent-driven innovation during public health emergencies

• Broad expertise validated through multiple technical certifications, workshops, and independent recognitions

Eligibility for the Young Scientist Award

Dr. Devika S. Kumar is recognized for her outstanding early-career contributions to biomedical science, reflected in her impactful research on neurodegeneration, autism biomarkers, infectious disease biology, and COVID-19 translational diagnostics. She has authored numerous peer-reviewed publications, contributed to major scientific book chapters, and developed multiple nationally published patents, including innovative PPE technologies and neuromodulating biomedical devices. Her work on oxidative stress markers in COVID-19 earned her the Young Researcher Award in 2022 and was featured in the WHO COVID-19 database. A Fellow of the Scholars Academic & Scientific Society and a certified researcher trained by WHO and NABL, Dr. Kumar exemplifies scientific rigor, innovation, and societal commitment. Her contributions significantly advance public health and translational medicine, making her an exemplary recipient of the Young Scientist Award.